Dr. Muthusamy Velusamy, MD

NPI: 1265432611
Total Payments
$36,164
2024 Payments
$6,422
Companies
50
Transactions
359
Medicare Patients
12,368
Medicare Billing
$1.4M

Payment Breakdown by Category

Other$16,980 (47.0%)
Food & Beverage$12,513 (34.6%)
Travel$6,638 (18.4%)
Education$33.02 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,513 325 34.6%
Long term medical supply or device loan $12,480 3 34.5%
Travel and Lodging $6,638 26 18.4%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,500 3 12.4%
Education $33.02 2 0.1%

Top Paying Companies

Company Total Records Latest Year
AngioDynamics, Inc. $15,354 11 $0 (2024)
Cook Incorporated $5,521 17 $0 (2018)
Boston Scientific Corporation $2,317 20 $0 (2024)
Philips Electronics North America Corporation $2,223 19 $0 (2023)
Abbott Laboratories $2,121 35 $0 (2024)
Penumbra, Inc. $1,343 5 $0 (2023)
Medtronic, Inc. $1,234 13 $0 (2023)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $960.19 54 $0 (2024)
AstraZeneca Pharmaceuticals LP $745.72 41 $0 (2024)
Inari Medical, Inc. $567.42 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $6,422 60 AngioDynamics, Inc. ($4,922)
2023 $6,362 63 AngioDynamics, Inc. ($4,800)
2022 $3,922 37 AngioDynamics, Inc. ($2,902)
2021 $1,605 31 Medtronic, Inc. ($1,160)
2020 $1,792 19 Philips Electronics North America Corporation ($1,317)
2019 $3,165 41 Penumbra, Inc. ($1,192)
2018 $8,045 61 Cook Incorporated ($3,077)
2017 $4,851 47 Cook Incorporated ($2,444)

All Payment Transactions

359 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/31/2024 AngioDynamics, Inc. VenaCure 1470 Pro (Device) Long term medical supply or device loan In-kind items and services $4,800.00 General
Category: ET
12/19/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $13.60 General
Category: Cardiology/Vascular Diseases
12/18/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $2.67 General
Category: Electromedical and Electrotherapeutic Apparatus
12/11/2024 Recor Medical Inc PARADISE RENAL DENERVATION SYSTEM (Device) Food and Beverage Cash or cash equivalent $176.80 General
Category: Endovascular
12/11/2024 Recor Medical Inc PARADISE RENAL DENERVATION SYSTEM (Device) Travel and Lodging Cash or cash equivalent $17.22 General
Category: Endovascular
12/05/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.43 General
Category: Cardiology
12/04/2024 Recor Medical Inc PARADISE RENAL DENERVATION SYSTEM (Device) Food and Beverage Cash or cash equivalent $9.00 General
Category: Endovascular
11/26/2024 ShockWave Medical, Inc Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) Food and Beverage In-kind items and services $41.24 General
Category: Lithoplasty
11/20/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $25.49 General
Category: CARDIOVASCULAR
11/19/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $20.07 General
Category: Cardiology
11/12/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $28.23 General
Category: Cardiovascular
10/30/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $19.90 General
Category: Cardiology
10/23/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $5.31 General
Category: Electromedical and Electrotherapeutic Apparatus
10/16/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $15.01 General
Category: CARDIOVASCULAR
10/02/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $6.44 General
Category: Electromedical and Electrotherapeutic Apparatus
09/24/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $29.96 General
Category: Cardiovascular
09/12/2024 Kiniksa Pharmaceuticals International, plc Arcalyst (Drug) Food and Beverage In-kind items and services $20.07 General
Category: Not Applicable
09/10/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.70 General
Category: Cardiovascular & Metabolism
09/03/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $14.03 General
Category: CARDIOVASCULAR
08/27/2024 Boston Scientific Corporation WATCHMAN FLX (Device) Food and Beverage In-kind items and services $17.28 General
Category: WATCHMAN FLX_IC
08/20/2024 AngioDynamics, Inc. VENACURE 1470 PRO (Device) Food and Beverage In-kind items and services $48.40 General
Category: VIT
08/20/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.20 General
Category: Cardiology
08/15/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.17 General
Category: Cardiovascular and Metabolism
08/13/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $62.46 General
Category: General - Tachy_CRM
08/12/2024 Boston Scientific Corporation EMBLEM MRI S-ICD (Device) Food and Beverage In-kind items and services $95.34 General
Category: EMBLEM_CRM

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 26 3,220 7,760 $1.3M $434,588
2022 31 3,324 6,528 $1.1M $362,296
2021 36 2,823 6,110 $963,129 $317,372
2020 32 3,001 6,932 $988,843 $307,461
Total Patients
12,368
Total Services
27,330
Medicare Billing
$1.4M
Procedure Codes
130

All Medicare Procedures & Services

130 procedure records from CMS Medicare Utilization — Page 1 of 6

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
36465 Injection of chemical agent into single incompetent vein of leg using ultrasound guidance Office 2023 37 134 $402,000 $135,869 33.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 279 751 $187,750 $73,302 39.0%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2023 82 83 $94,501 $27,211 28.8%
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose Office 2023 77 154 $33,880 $26,855 79.3%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 159 170 $85,000 $25,038 29.5%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 124 134 $67,000 $18,414 27.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 83 122 $42,500 $16,877 39.7%
93970 Ultrasound study of arm or leg veins with compression and maneuvers Office 2023 81 93 $44,175 $13,387 30.3%
93971 Ultrasound study of one arm or leg veins with compression and maneuvers Office 2023 39 137 $37,675 $12,510 33.2%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 75 79 $39,500 $11,695 29.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 87 172 $30,960 $10,664 34.4%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2023 190 199 $31,840 $10,489 32.9%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 1,269 1,573 $31,460 $9,926 31.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 64 64 $25,600 $8,364 32.7%
93978 Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts Office 2023 33 35 $16,625 $4,836 29.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 41 50 $13,000 $4,540 34.9%
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician Office 2023 81 82 $15,170 $3,937 26.0%
93925 Ultrasound of leg arteries or artery grafts Office 2023 19 21 $13,125 $3,915 29.8%
93458 Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist Facility 2023 20 21 $17,430 $3,696 21.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 19 19 $9,500 $3,350 35.3%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 195 266 $10,640 $3,016 28.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 22 23 $8,050 $2,427 30.2%
93280 Programming of dual lead pacemaker system Office 2023 23 34 $5,100 $2,060 40.4%
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) Office 2023 58 3,279 $5,203 $1,349 25.9%
93272 Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional Office 2023 23 23 $1,495 $423.50 28.3%

About Dr. Muthusamy Velusamy, MD

Dr. Muthusamy Velusamy, MD is a Cardiovascular Disease healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265432611.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muthusamy Velusamy, MD has received a total of $36,164 in payments from pharmaceutical and medical device companies, with $6,422 received in 2024. These payments were reported across 359 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($12,513).

As a Medicare-enrolled provider, Velusamy has provided services to 12,368 Medicare beneficiaries, totaling 27,330 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Other Specialties Interventional Cardiology, Nuclear Cardiology
  • Location Tampa, FL
  • Active Since 07/28/2005
  • Last Updated 07/23/2020
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1265432611

Products in Payments

  • VenaCure 1470 Pro (Device) $12,480
  • COOK MEDICAL ZILVER PTX (Device) $1,618
  • ANGIOJET (Device) $1,573
  • COOK MEDICAL IAA (Device) $1,500
  • Cook Medical IAA (Device) $1,500
  • IGT D Peripheral (Device) $1,317
  • Indigo (Device) $1,192
  • Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $1,009
  • Micra (Device) $1,005
  • LifeVest (Device) $960.19
  • Cook Medical Peripheral Intervention (Device) $640.86
  • Supera peripheral stent system (Device) $586.36
  • FlowTriever (Device) $567.42
  • Repatha (Biological) $463.61
  • Prod. Category: IVUS Imaging (Device) $370.78
  • FARXIGA (Drug) $354.34
  • BRILINTA (Drug) $350.06
  • IGT_D Peripheral (Device) $313.39
  • VERQUVO (Drug) $294.38
  • OptoWire (Device) $245.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Tampa